BUSINESS
Pharma wrap: Coronavirus outbreak, time to be on high alert
So far there was no case detected of the novel cornonavirus infection in India.
BUSINESS
Coronavirus: CEPI begins work on three new vaccines
For developing these vaccines CEPI has partnered with US-based biotech companies Inovio and Moderna; and the University of Queensland, Australia.
BUSINESS
Biocon Q3 profit down 7% at Rs 203 crore
Revenues rose YoY 14 percent to Rs 1784 crore in the third quarter.
BUSINESS
Budget 2020: A look at pharma sector's wishlist for FM Nirmala Sitharaman
The pharma companies are also hopes the government will announce incentives in the Budget to encourage setting up bulk drug manufacturing units in the country.
BUSINESS
Psychiatric body condemns use of stem cell therapies to treat psychiatric disorders
IPS in its position statement on stem cell therapy on January 17, said till now there is no scientifically validated and scrutinized research evidences which proves that stem cells are helpful in any psychiatric disorders including autism.
INDIA
Why India needs to keep an eye on the new coronavirus outbreak in China
The pneumonia outbreak in China's Wuhan city in Hubei province in December 2019, is said to have been caused by a new coronavirus, coming from the same family of viruses that caused SARS in 2003
BUSINESS
Ajay Piramal says will use proceeds of DRG sale to grow financial services biz
"In the NBFC (Non-banking Finance Company) space, many of the NBFCs have actually stopped lending or reduced their lending and therefore this gives us an opportunity to grow organically " said Ajay Piramal.
BUSINESS
Piramal Enterprises sells healthcare analytics biz to Clarivate for $950mn
PEL had initially invested $650 million in 2012 to acquire DRG, of which $260 million was infused as equity
BUSINESS
Explained: The fissure between pharma industry & doctors' body over PM Modi's comment
The reason behind the controversy is a study co-authored by Dr Arun Gadra and Dr Archana Diwate, titled 'Promotional Practices of the Pharmaceutical Industry and Implementation Status of Related Regulatory Codes in India'.
BUSINESS
Wockhardt becomes first Indian co to get DCGI nod for 2 new antibiotics
Khorakiwala said the company will be launching the two drugs in next few months in India and later in emerging markets and China.
BUSINESS
Healthcare bodies IPA, IMA differ on media reports of doctors taking bribes
Earlier - the Indian Medical Association (IMA) - the body representing doctors in India, took a strong exception to the development.
BUSINESS
Lupin's US FDA compliance woes suggest the problem runs deeper
Tarapur is Lupin’s fifth facility in the past 12 months to be hit by regulatory compliance issues.
BUSINESS
California's move to sell generic drugs under own label may adversely affect India drug companies
"Every government will like to bring down the cost of medication. Currently the US market is fed through intermediaries. So, understandably they (California) want to cut back on the intermediaries, which have a hefty margins upwards of 10-20 percent," said Dinesh Dua, Chairman of Pharmaceuticals Export Promotion Council (Pharmexcil).
BUSINESS
PPP medical colleges — NITI Aayog's plan to address shortage of doctors
NITI Aayog has said that the proposed plan is to bring private capital to setup medical colleges and privatise operations, and management of the associated district hospital is to address shortage of qualified doctors
BUSINESS
Indian pharma market sees growth of 9.6% in Q3FY20
Growth moderated due to dip in sales of anti-infectives, gastrointestinal, pain and vitamins segments and lower inventory levels, compared to previous year.
BUSINESS
Looking to snap up Integrated Vaccine Complex, Bharat Biotech is on a steady growth path
Bharat Biotech was founded in 1994 by yeast molecular biologist Krishna Ella and his wife Suchitra Ella.
BUSINESS
Edutech platform Omnicuris is reshaping the upskilling of doctors in India, here's how
Omnicuris uses video as a medium of instruction, and offers the courses for free. The platform is also interactive, allowing doctors to ask questions to experts, take part in webinars, quizzes, assignments and assessments, among other things.
BUSINESS
Biocon Biologics IPO: Syngene encore on the cards
Syngene, which was listed in August 2015, raised Rs 550 crore. The IPO was subscribed 32 times. Incidentally, True North was an investor in Syngene before it was listed.
BUSINESS
Steer Engineering reaches out-of-court settlement with GSK over Horlicks
GSK's nutrition business is largely led by the Horlicks brand.
BUSINESS
Indian hospital revenues set to make a strong comeback in FY20
After two years of subdued performance, the hospital sector is set to bounce back in FY20, posting revenue growth of 10-12 percent in the short to medium term, ICRA said.
BUSINESS
How Christiane Hamacher looks to steer Biocon Biologics towards $1 billion sales mark
The company has set an ambitious target of clocking $1 billion in sales by FY22 through its biologics division, which is at near fourfold jump in terms of sales from FY19.
BUSINESS
Novo Nordisk names Vikrant Shrotriya as new India head
Shrotriya has over 20 years of experience in the healthcare industry.
BUSINESS
How e-commerce portal Biomall is trying to disrupt the lab products space
Products from multiple brands can be procured by a lab user located in any part of the world in a single order.
BUSINESS
Alkem Labs acquires anti-nausea drug Marinol from AbbVie for $10 million
Marionol capsules are used to treat the loss of appetite (anorexia) in AIDS patients and to treat nausea and vomiting in patients receiving chemotherapy.
